| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699871 | Clinical Oncology | 2006 | 6 Pages |
Abstract
There is no evidence for an influence of pre-treatment haemoglobin levels on the clinical response to neoadjuvant chemotherapy in breast cancer. It is unlikely that correction of anaemia above that which is warranted clinically will improve outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.J. Beresford, R. Burcombe, M.-L. Ah-See, D. Stott, A. Makris,